260 related articles for article (PubMed ID: 9472030)
1. Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.
Gilboa L; Wells RG; Lodish HF; Henis YI
J Cell Biol; 1998 Feb; 140(4):767-77. PubMed ID: 9472030
[TBL] [Abstract][Full Text] [Related]
2. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
[TBL] [Abstract][Full Text] [Related]
4. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles.
Roy SK; Kole AR
Mol Hum Reprod; 1998 Mar; 4(3):207-14. PubMed ID: 9570266
[TBL] [Abstract][Full Text] [Related]
5. The types II and III transforming growth factor-beta receptors form homo-oligomers.
Henis YI; Moustakas A; Lin HY; Lodish HF
J Cell Biol; 1994 Jul; 126(1):139-54. PubMed ID: 8027173
[TBL] [Abstract][Full Text] [Related]
6. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
7. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation.
Wells RG; Yankelev H; Lin HY; Lodish HF
J Biol Chem; 1997 Apr; 272(17):11444-51. PubMed ID: 9111056
[TBL] [Abstract][Full Text] [Related]
9. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
Deng X; Bellis S; Yan Z; Friedman E
Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
11. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.
Gilboa L; Nohe A; Geissendörfer T; Sebald W; Henis YI; Knaus P
Mol Biol Cell; 2000 Mar; 11(3):1023-35. PubMed ID: 10712517
[TBL] [Abstract][Full Text] [Related]
13. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
14. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
Feng XH; Derynck R
EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
[TBL] [Abstract][Full Text] [Related]
15. Single-molecule imaging reveals transforming growth factor-beta-induced type II receptor dimerization.
Zhang W; Jiang Y; Wang Q; Ma X; Xiao Z; Zuo W; Fang X; Chen YG
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15679-83. PubMed ID: 19720988
[TBL] [Abstract][Full Text] [Related]
16. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
Doré JJ; Edens M; Garamszegi N; Leof EB
J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
[TBL] [Abstract][Full Text] [Related]
17. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
[TBL] [Abstract][Full Text] [Related]
18. Constitutive homo- and hetero-oligomerization of TbetaRII-B, an alternatively spliced variant of the mouse TGF-beta type II receptor.
Krishnaveni MS; Hansen JL; Seeger W; Morty RE; Sheikh SP; Eickelberg O
Biochem Biophys Res Commun; 2006 Dec; 351(3):651-7. PubMed ID: 17078931
[TBL] [Abstract][Full Text] [Related]
19. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
Tazat K; Hector-Greene M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
